These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16424426)

  • 1. Reduced histone deacetylase in COPD: clinical implications.
    Barnes PJ
    Chest; 2006 Jan; 129(1):151-5. PubMed ID: 16424426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of HDAC2 in the pathophysiology of COPD.
    Barnes PJ
    Annu Rev Physiol; 2009; 71():451-64. PubMed ID: 18817512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
    Ito K; Ito M; Elliott WM; Cosio B; Caramori G; Kon OM; Barczyk A; Hayashi S; Adcock IM; Hogg JC; Barnes PJ
    N Engl J Med; 2005 May; 352(19):1967-76. PubMed ID: 15888697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylation: an important mechanism in inflammatory lung diseases.
    Adcock IM; Ito K; Barnes PJ
    COPD; 2005 Dec; 2(4):445-55. PubMed ID: 17147010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase-2 and airway disease.
    Barnes PJ
    Ther Adv Respir Dis; 2009 Oct; 3(5):235-43. PubMed ID: 19812111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Airway inflammation in COPD].
    Muro S
    Nihon Rinsho; 2007 Apr; 65(4):644-7. PubMed ID: 17419382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone acetylation and deacetylation: importance in inflammatory lung diseases.
    Barnes PJ; Adcock IM; Ito K
    Eur Respir J; 2005 Mar; 25(3):552-63. PubMed ID: 15738302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids: the drugs to beat.
    Barnes PJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):2-14. PubMed ID: 16436275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease.
    Barnes PJ
    Proc Am Thorac Soc; 2009 Dec; 6(8):693-6. PubMed ID: 20008877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of chronic inflammation in lung diseases: new therapeutic approach.
    Mroz RM; Noparlik J; Chyczewska E; Braszko JJ; Holownia A
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):453-60. PubMed ID: 18204158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment.
    Barnes PJ
    Expert Opin Ther Targets; 2005 Dec; 9(6):1111-21. PubMed ID: 16300464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of airway inflammation.
    Adcock IM; Tsaprouni L; Bhavsar P; Ito K
    Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Theophylline, a new look to an old drug].
    Morfín Maciel BM; Castillo Morfín BM
    Rev Alerg Mex; 2010; 57(4):112-22. PubMed ID: 21255523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pathogenesis of chronic obstructive pulmonary disease, steroid resistance and the place of theophylline in the treatment].
    Bayram H
    Tuberk Toraks; 2009; 57(1):115-24. PubMed ID: 19533448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.
    Barnes PJ; Ito K; Adcock IM
    Lancet; 2004 Feb; 363(9410):731-3. PubMed ID: 15001333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COPD unwound.
    Shapiro SD
    N Engl J Med; 2005 May; 352(19):2016-9. PubMed ID: 15888704
    [No Abstract]   [Full Text] [Related]  

  • 17. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages.
    Cosio BG; Tsaprouni L; Ito K; Jazrawi E; Adcock IM; Barnes PJ
    J Exp Med; 2004 Sep; 200(5):689-95. PubMed ID: 15337792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy.
    Marwick JA; Ito K; Adcock IM; Kirkham PA
    Expert Opin Ther Targets; 2007 Jun; 11(6):745-55. PubMed ID: 17504013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoke exposure of human macrophages reduces HDAC3 activity, resulting in enhanced inflammatory cytokine production.
    Winkler AR; Nocka KN; Williams CM
    Pulm Pharmacol Ther; 2012 Aug; 25(4):286-92. PubMed ID: 22613758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte senescence in COPD is associated with decreased histone deacetylase 2 expression by pro-inflammatory lymphocytes.
    Hodge G; Jersmann H; Tran HB; Roscioli E; Holmes M; Reynolds PN; Hodge S
    Respir Res; 2015 Oct; 16():130. PubMed ID: 26498345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.